fda tirzepatide compounding warning 2024 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our September 2, 2025: U.S. compounding

Treatments that mimic GLP-1 can assist with type 2 diabetes and weight management, but consulting with a healthcare provider is essential before starting

That matters because the easier treatment feels to stay with, the easier it becomes to stay consistent

"Anything is possible when an FDA-approved drug is taken inappropriately." However, for people who develop gastroparesis or pancreatitis, potential complications can include dehydration and kidney damage

Can I take over-the-counter medications for acid reflux while on retatrutide

I dont, for instance, want to blow my drug budget prescribing edoxaban just because some grubby deal has been done by the DOH